Open Journal of Gastroenterology
Vol.2 No.2(2012), Paper ID 18318, 4
pages
DOI:10.4236/ojgas.2012.22015
Impact of Lamivudine plus Adefovir therapy in chronic hepatitis B Iranian patients, resistant to Lamivudine treatment alone, on disease inhibition: A pilot study
Arezoo Estakhri, Ashraf Mohamadkhani, Hosein Poustchi, Ghodrat Montazeri
Digestive Disease Research Institute(DDRI) ,Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
Digestive Disease Research Institute(DDRI) ,Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
Digestive Disease Research Institute(DDRI) ,Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
Digestive Disease Research Institute(DDRI) ,Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
Copyright © 2012 Arezoo Estakhri, Ashraf Mohamadkhani, Hosein Poustchi, Ghodrat Montazeri et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Estakhri, A. , Mohamadkhani, A. , Poustchi, H. and Montazeri, G. (2012) Impact of Lamivudine plus Adefovir therapy in chronic hepatitis B Iranian patients, resistant to Lamivudine treatment alone, on disease inhibition: A pilot study.
Open Journal of Gastroenterology,
2, 72-75. doi:
10.4236/ojgas.2012.22015.